Journal of Global Pharma Technology
Volume 16 Issue 10 (2024) October 2024

RECENT DRUG DISCOVERY STATUS AGAINST PEPTIC ULCER

Panda, Girija Shankar (Unknown)
Sahoo, Deeptitapa (Unknown)
Ray, Jassaswi (Unknown)
Mohanty, R. (Unknown)
Nayak, Ritesh Kumar (Unknown)



Article Info

Publish Date
05 Oct 2024

Abstract

Peptic ulcer is a customary disease, it affecting around 5-10% of the general population worldwide, but with notable regional and rectal variants. The two most common etiological causes are the chronic infection with Helicobacter Pylori (HP) and the uses of nonsteroidal anti-inflammatory drugs (NSAIDS). Its diagnosis is based mainly in the endoscopy and the active search of contaminant Helicobacter pylori presence. Peptic ulcers are found to be due to an imbalance between aggressive factors such as hydrochloric acid, pepsin, refluxed bile, leukotrienes, relative oxygen species and defensive factors, which include the function of the mucus, bicarbonate barrier, prostaglandins, mucosal blood flow, cell renewal and migration, non-enzymatic and enzymatic antioxidants and some growth factors. Keywords: Helicobacter Pylori, NSAID, Proton Pump Inhibiter, Leukotriene, Bicarbonate Barrier, Refluxed Bile.

Copyrights © 2024






Journal Info

Abbrev

jgpt

Publisher

Subject

Medicine & Pharmacology

Description

ournal of Global Pharma Technology is a monthly, open access, Peer review journal of Pharmacy published by JGPT Journal publishes peer-reviewed original research papers, case reports and systematic reviews. The journal allows free access to its contents, which is likely to attract more readers and ...